A survey of coronary risk factors and B-type natriuretic peptide concentrations in cardiac nurses from Europe: Do nurses still practice what they preach?

European Journal of Cardiovascular Nursing

Volumn 3, Issue 1, 2004, Pages 3-6

  Jaarsma, Tiny ^a,b   Stewart, Simon ^a   De Geest, Sabina ^a   Fridlund, Bengt ^a   Heikkilä, Johanna ^a   Mårtensson, Jan ^a   Moons, Philip ^a   Scholte Op Reimer, Wilma ^a   Smith, Karen ^a   Strömberg, Anna ^a   Thompson, David R ^a  

^a Undertaking Nursing Interventions T ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

B type natriuretic peptide; Cardiovascular risk factors; Nurses

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; POTASSIUM DERIVATIVE;

ADULT; AGE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EUROPE; EXERCISE; FEMALE; FLUORESCENCE; HEALTH STATUS; HEALTH SURVEY; HUMAN; IMMUNOASSAY; ISCHEMIC HEART DISEASE; MALE; MEDICAL PRACTICE; NETHERLANDS; NORMAL HUMAN; NURSE; NURSING; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SAMPLING; SCORING SYSTEM; SCREENING; SELF REPORT; SEX; SMOKING; STATISTICAL SIGNIFICANCE; TIME; TUBE; VENOUS BLOOD;

ADULT; ATTITUDE TO HEALTH; CARDIOLOGY; CORONARY DISEASE; DIABETES COMPLICATIONS; EUROPE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MASS SCREENING; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NURSE CLINICIANS; OBESITY; RISK ASSESSMENT; RISK FACTORS;

EID: 12144285689     PISSN: 14745151     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcnurse.2004.01.005     Document Type: Review

References (20)

1. Lindbloom E. America's aging population: changing the face of health care. J Am Med Assoc. 269:1993;674-679.
2. Tunstall-Pedoe H., Kuulasmaa K., Mahonen M., Tolonen H., Ruokokoski E., Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10 year results from 37 WHO MONICA Project populations. Lancet. 353:1999;1547-1557.
3. Gray A.M., Bowman G.S., Thompson D.R. The cost of cardiac rehabilitation services in England and Wales. J Roy Coll Phys Lond. 31:1997;57-61.
4. Thompson D.R., Stewart S. Nurse-directed services: how can them made to be more effective? Eur J Cardiovasc Nurs. 1:2002;7-10.
5. Kavanagh T., Shephard R.J., Hamm L.F., Mertens D.J., Thacker L. Risk profile and health awareness in male off-spring of parents with premature coronary heart disease. J Cardiopulm Rehabil. 20:2000;172-179.
6. Barrett T.W., Norton V.C., Busam M., Boyd J., Maron D.J., Slovis C.M. Self-reported cardiac risk factors in emergency department nurses and paramedics. Prehosp Disaster Med. 15:2000;68-79.
7. Connolly M.A., Gulanik M., Keough V., Holm K. Health practices of critical care nurses: are these good role models for patients? Am J Crit Care. 6:1997;261-266.
8. Undertaking Nursing Interventions Throughout Europe (UNITE) Study Group. A survey of coronary risk factors in a cohort of cardiac nurses from Europe: do nurses practice what they preach? Eur J Cardiovasc Nurs. 1:2002;57-60.
9. Hamm C.W., Goldman B.W., Heeschen C., Kreymnn G., Berger J., Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 337:1997;1648-1653.
10. Sayre M.R., Kaufmann K.H., Chen I., et al. Measurement of cardiac troponin T is an effective method of predicting complications among emergency department patients with chest pain. Ann Emerg Med. 31:1998;539-549.
11. Berger R., Stanek B., Frey B., et al. B-type natriuretic peptides (BNP and PRO-BNP) predict longterm survival in patients with advanced heart failure treated with atenolol. J Heart Lung Transplant. 20:2001;251.
12. McDonagh T.A., Cunningham A.D., Morrison C.E., et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart. 86:2001;21-26.
13. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 105:2002;2392-2397.
14. Bettencourt P., Ferreira S., Azevedo A., Ferreira A. Preliminary data on the potential usefulness of B type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure. Am J Med. 113:2002;215-219.
15. Safely D.M., McCullough P.A. The emerging role of brain natriuretic peptide in the management of acute and chronic heart failure in outpatients. Heart Monit. 4:2003;13-20.
16. Troughton R.W., Frampton C.M., Yandle T.G., Epsiner E.A., Nicholls M.G., Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 355:2000;1126-1130.
17. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al.; Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type Natriuretic peptide in an emergency diagnosis of heart failure. New Engl J Med 2002; 347:161-167
18. Chobanian AV, Bakris GL, Black HR, et al. for the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 2003; 289(19):2560-2572
19. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. N Engl J Med. 347:(5):2002 Aug 1;305-313.
20. Nielsen O.W., McDonagh T.A., Robb S.D., Dargie H.J. Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population. J Am Coll Cardiol. 41:2003;113-120.